We are excited to announce that ViewMind Inc. will present new results to identify frontotemporal dementia in the MCI stage (prodromal FTD) and to differentiate against Alzheimer’s disease in the MCI stage (prodromal AD).

Patients were tracked in a 4-year prospective study until the underlying causality of MCI was clinically diagnosed.

Start-Ups Shaking Things Up in Health Sector at MEDICA

The internationally leading medical trade fair MEDICA (Düsseldorf, Germany) has long been recognized as a global platform for health sector startups.

CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic

Unequal access to cognitive healthcare is a key barrier to reducing the ever-increasing rates of brain and neurodegenerative health disorders worldwide.

ViewMind, As Featured On Public Television

ViewMind, As Featured On Public Television Homepage >> News >> ViewMind, As Featured On Public Television Click to read the news Related Posts

ViewMind Inc. is greatly honored to have been awarded 1st place by the judges at the final of the 14th Healthcare Innovation World Cup® at MEDICA

ViewMind Inc. is greatly honored to have been awarded 1st place by the judges at the final of the 14th Healthcare Innovation World Cup® at MEDICA Homepage >> News >> ViewMind Inc. is greatly honored to have been awarded 1st place by the judges at the final of the 14th Healthcare Innovation World Cup® at… Continue reading ViewMind Inc. is greatly honored to have been awarded 1st place by the judges at the final of the 14th Healthcare Innovation World Cup® at MEDICA

Can Artificial Intelligence Help Forestall the Global Dementia Epidemic?

An unmatched tool for early detection of cognitive alterations

The Race Against Long-Covid

The Race Against Long-Covid Homepage >> News >> The Race Against Long-Covid The Race against Long-Covid – By Leesa Soulodre   Click to read the news Related Posts

Cracking the cognitive effects of Long COVID

Cracking the cognitive effects of Long COVID Homepage >> News >> Cracking the cognitive effects of Long COVID CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms Click to read the news Related Posts

ViewMind Inc. is featured today on CBS News

ViewMind Inc. is featured today on CBS News Homepage >> News >> ViewMind Inc. is featured today on CBS News  Click to read the news Related Posts

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s Homepage >> News >> Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease Related Posts